Arthur J Klausner insider trades

Open-market stock purchases and sales by Arthur J Klausner, Director at Monopar Therapeutics, from SEC Form 4 filings since Aug 9, 2018.

Recent trades

DateStockTradeValue
Dec 18, 2025MNPR Monopar TherapeuticsSold$312K
Dec 18, 2025MNPR Monopar TherapeuticsSold$31.4K
Dec 16, 2025MNPR Monopar TherapeuticsBought (not open market)—
Dec 2, 2025MNPR Monopar TherapeuticsBought (not open market)—

Companies traded

  • MNPR Monopar Therapeutics: 2 sales, last Dec 18, 2025
  • NONE Monopar Therapeutics: other filings, last Aug 9, 2018

Get free alerts when Arthur J Klausner files a new trade →